Financhill
Back

Cullinan Therapeutics Vs. Agios Pharmaceuticals Industry Stock Comparison

Sell
29

CGEM
Cullinan Therapeutics

Last Price:
11.76
Seasonality Move:
24.73%
Sell
2

AGIO
Agios Pharmaceuticals

Last Price:
38.94
Seasonality Move:
20.75%
Sell
29
Cullinan Therapeutics (CGEM) is a Sell

Is Cullinan Therapeutics a Buy, Sell or Hold?

  • The current Cullinan Therapeutics [CGEM] share price is $11.75. The Score for CGEM is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • CGEM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Agios Pharmaceuticals (AGIO) is a Sell

Is Agios Pharmaceuticals a Buy, Sell or Hold?

  • The current Agios Pharmaceuticals [AGIO] share price is $38.97. The Score for AGIO is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CGEM Stock Price Chart

What is Cullinan Therapeutics's stock price today?

  • The Cullinan Therapeutics share price today is $11.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGEM is experiencing slight selling pressure.

AGIO Stock Price Chart

What is Agios Pharmaceuticals's stock price today?

  • The Agios Pharmaceuticals share price today is $38.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

CGEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.77 Sell
Relative Strength Index (14 RSI): 32.7 Sell
Chaikin Money Flow: -156514 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.03 - 14.87) Sell
Bollinger Bands (100): (14.23 - 18.37) Sell

AGIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.2 Sell
Relative Strength Index (14 RSI): 28.25 Sell
Chaikin Money Flow: 740295 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.22 - 61.14) Sell
Bollinger Bands (100): (41.85 - 53.15) Sell

CGEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.52 Sell
20-day SMA: 12.79 Sell
50-day SMA: 14.79 Sell
200-day SMA: 18.02 Sell
8-day EMA: 12.44 Sell
20-day EMA: 13.1 Sell
50-day EMA: 14.47 Sell
200-day EMA: 16.16 Sell

AGIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.4 Sell
20-day SMA: 53.73 Sell
50-day SMA: 49.6 Sell
200-day SMA: 41.93 Sell
8-day EMA: 46.69 Sell
20-day EMA: 51.08 Sell
50-day EMA: 50.45 Sell
200-day EMA: 42.79 Sell

Cullinan Therapeutics Earnings Growth & CGEM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and a decrease next year of $0.12 per share.

Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.

Cullinan Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Agios Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):